Viking Therapeutics, Inc.
VKTXW
VKTXW was delisted on the 8th of April, 2021.
4 hedge funds and large institutions have $1.48M invested in Viking Therapeutics, Inc. in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
43% more capital invested
Capital invested by funds: $1.03M → $1.48M (+$443K)
0% more funds holding
Funds holding: 4 → 4 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OFG
OTA Financial Group
Purchase,
New York
|
+$163K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair & Company
Chicago,
Illinois
|
-$71.9K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$35.7K |
| 3 |
US Bancorp
Minneapolis,
Minnesota
|
-$18K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PWAM
1
Park West Asset Management
San Francisco,
California
| $800K | – | – | – |
|
|
2
William Blair & Company
Chicago,
Illinois
| $427K | -$71.9K | -10,525 | -17% |
|
|
OFG
3
OTA Financial Group
Purchase,
New York
| $214K | +$163K | +23,883 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $34K | -$35.7K | -5,235 | -56% |
|
|
5
US Bancorp
Minneapolis,
Minnesota
| – | -$18K | -3,000 | Closed |
|
VKTXW Hedge Fund Activity: Q1 2019 in Review
4 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics, Inc. (VKTXW) for Q1 2019, worth a combined $1.48M — up 43% from $1.03M a quarter earlier.
Fund positioning in VKTXW was balanced in Q1 2019: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 2 trimmed.
The largest buyer was OTA Financial Group, opening a new position worth an estimated $163K. The largest seller was William Blair & Company, cutting an estimated $71.9K.
- 4 institutional investors held Viking Therapeutics, Inc. (VKTXW) as of Q1 2019, unchanged from Q4 2018.
- Funds reported $1.48M of Viking Therapeutics, Inc. stock for Q1 2019, up 43% quarter-over-quarter.
- 1 fund opened new Viking Therapeutics, Inc. positions in Q1 2019 and 1 closed out, a net change of 0 holders.
- The largest Viking Therapeutics, Inc. buyer in Q1 2019 was OTA Financial Group, an estimated $163K added.
- The largest Viking Therapeutics, Inc. seller in Q1 2019 was William Blair & Company, an estimated $71.9K sold.
Based on aggregated 13F filings for Q1 2019.